Lunate Capital Ltd
Position in NMRA — Neumora Therapeutics, Inc.
CIK 2056786
AL MARYAH ISLAND, ABU DHABI, C0
Position in NMRA
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$3,611,043
-$531,035 QoQ
Shares Held
2,124,143
0.0% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
1.84%
of 13F equity value
Holder Rank
#11
of 111 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NMRA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Lunate Capital Ltd holds $3,611,043 across 1 Biotechnology name. NMRA ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NMRA |
Neumora Therapeutics, Inc.
This page
|
2,124,143 | $3,611,043 |
All Filings in NMRA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,611,043 | 2,124,143 | Shares | Defined | 2026-07-23 | |
| 2026-03-31 | $4,142,078 | 2,124,143 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $3,802,215 | 2,124,143 | Shares | Defined | 2026-01-23 | |
| 2025-09-30 | $3,865,940 | 2,124,143 | Shares | Defined | 2025-11-20 | |
| 2025-06-30 | $1,556,996 | 2,124,143 | Shares | Defined | 2025-07-17 | |
| 2025-03-31 | $2,124,143 | 2,124,143 | Shares | Defined | 2025-04-25 | |
| No filing history on record for this holder in this stock. | ||||||